% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{DemnitzKing:164983,
author = {Demnitz-King, Harriet and Gonneaud, Julie and Klimecki,
Olga M and Chocat, Anne and Collette, Fabienne and
Dautricourt, Sophie and Jessen, Frank and Krolak-Salmon,
Pierre and Lutz, Antoine and Morse, Rachel M and Molinuevo,
José Luis and Poisnel, Géraldine and Touron, Edelweiss and
Wirth, Miranka and Walker, Zuzana and Chételat, Gaël and
Marchant, Natalie L},
collaboration = {Group, Medit-Ageing Research},
title = {{A}ssociation {B}etween {S}elf-{R}eflection, {C}ognition,
and {B}rain {H}ealth in {C}ognitively {U}nimpaired {O}lder
{A}dults.},
journal = {Neurology},
volume = {99},
number = {13},
issn = {0028-3878},
address = {[S.l.]},
publisher = {Ovid},
reportid = {DZNE-2022-01387},
pages = {e1422 - e1431},
year = {2022},
abstract = {Self-reflection (the active evaluation of ones thoughts,
feelings and behaviours) can confer protection against
adverse health outcomes. Its impact on markers sensitive to
Alzheimer's disease (AD), however, is unknown. The primary
objective of this cross-sectional study was to examine the
association between self-reflection and AD-sensitive
markers.This study utilised baseline data from cognitively
unimpaired older adults enrolled in the Age-Well clinical
trial and older adults with subjective cognitive decline
from the SCD-Well clinical trial. In both cohorts,
self-reflection was measured via the reflective pondering
subscale of the Rumination Response Scale, global cognition
assessed via the Preclinical Alzheimer's Cognitive Composite
5, and a modified late-life Lifestyle-for-Brain-Health
(LIBRA) index computed to assess health and lifestyle
factors. In Age-Well, glucose metabolism and amyloid
deposition were quantified in AD-sensitive grey matter
regions via FDG- and AV45-PET scans, respectively.
Associations between self-reflection and AD-sensitive
markers (global cognition, glucose metabolism, and amyloid
deposition) were assessed via unadjusted and adjusted
regressions. Further, we explored whether associations were
independent of health and lifestyle factors. To control for
multiple comparisons in Age-Well, false discovery rate
corrected p-values (p FDR) are reported.A total of 134 (mean
age 69.3 ± 3.8 years, $61.9\%$ female) Age-Well and 125
(mean age 72.6 ± 6.9 years, $65.6\%$ female) SCD-Well
participants were included. Across unadjusted and adjusted
analyses self-reflection was positively associated with
global cognition in both cohorts (Age-Well: adjusted-β =
0.22, $95\%$ confidence interval [CI] 0.05-0.40, p FDR =
0.041; SCD-Well: adjusted-β = 0.18, $95\%$ CI 0.03-0.33, p
= 0.023) and with glucose metabolism in Age-Well after
adjustment for all covariates (adjusted-β = 0.29, $95\%$ CI
0.03-0.55, p FDR = 0.041). Associations remained following
additional adjustment for LIBRA but did not survive FDR
correction. Self-reflection was not associated with amyloid
deposition (adjusted-β = 0.13, $95\%$ CI -0.07-0.34, p FDR
= 0.189).Self-reflection was associated with better global
cognition in two independent cohorts and with higher glucose
metabolism after adjustment for covariates. There was weak
evidence that relationships were independent from health and
lifestyle behaviours. Longitudinal and experimental studies
are warranted to elucidate whether self-reflection helps
preserve cognition and glucose metabolism, or whether
reduced capacity to self-reflect is a harbinger of cognitive
decline and glucose hypometabolism.Age-Well: NCT02977819;
SCD-Well: NCT03005652.},
keywords = {Aged / Alzheimer Disease: metabolism / Amyloid
beta-Peptides: metabolism / Biomarkers: metabolism / Brain:
diagnostic imaging / Brain: metabolism / Cognition:
physiology / Cognitive Dysfunction: diagnostic imaging /
Cognitive Dysfunction: metabolism / Cross-Sectional Studies
/ Female / Glucose: metabolism / Humans / Magnetic Resonance
Imaging / Male / Positron-Emission Tomography / Amyloid
beta-Peptides (NLM Chemicals) / Biomarkers (NLM Chemicals) /
Glucose (NLM Chemicals)},
cin = {AG Wirth / AG Donix},
ddc = {610},
cid = {I:(DE-2719)1710011 / I:(DE-2719)1710008},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:35853750},
doi = {10.1212/WNL.0000000000200951},
url = {https://pub.dzne.de/record/164983},
}